Non-steroidal anti-inflammatory drugs for the common cold
Soo Young Kim, Yoon-Jung Chang, Hye Min Cho, Ye-Won Hwang, Yoo Sun Moon, Soo Young Kim, Yoon-Jung Chang, Hye Min Cho, Ye-Won Hwang, Yoo Sun Moon
Abstract
Background: Non-steroidal anti-inflammatory drugs (NSAIDs) have been widely used for the treatment of pain and fever associated with the common cold.
Objectives: To determine the effects of NSAIDs versus placebo (and other treatments) on signs and symptoms of the common cold, and to determine any adverse effects of NSAIDs in people with the common cold.
Search methods: We searched CENTRAL (2015, Issue 4, April), (January 1966 to April week 3, 2015), EMBASE (January 1980 to April 2015), CINAHL (January 1982 to April 2015) and ProQuest Digital Dissertations (January 1938 to April 2015).
Selection criteria: Randomised controlled trials (RCTs) of NSAIDS in adults or children with the common cold.
Data collection and analysis: Four review authors extracted data. We subdivided trials into placebo-controlled RCTs and head-to-head comparisons of NSAIDs. We extracted and summarised data on global analgesic effects (such as reduction of headache and myalgia), non-analgesic effects (such as reduction of nasal symptoms, cough, sputum and sneezing) and side effects. We expressed dichotomous outcomes as risk ratios (RR) with 95% confidence intervals (CI) and continuous data as mean differences (MD) or standardised mean differences (SMD). We pooled data using the fixed-effect and random-effects models.
Main results: We included nine RCTs with 1069 participants, describing 37 comparisons: six were NSAIDs versus placebo and three were NSAIDs versus NSAIDs. The overall risk of bias in the included studies was mixed. In a pooled analysis, NSAIDs did not significantly reduce the total symptom score (SMD -0.40, 95% CI -1.03 to 0.24, three studies, random-effects model), or duration of colds (MD -0.23, 95% CI -1.75 to 1.29, two studies, random-effects model). For respiratory symptoms, cough did not improve (SMD -0.05, 95% CI -0.66 to 0.56, two studies, random-effects model) but the sneezing score significantly improved (SMD -0.44, 95% CI -0.75 to -0.12, two studies, random-effects model). For outcomes related to the analgesic effects of NSAIDs (headache, ear pain, and muscle and joint pain) the treatment produced significant benefits. The risk of adverse effects was not high with NSAIDs (RR 2.94, 95% CI 0.51 to 17.03, two studies, random-effects model) but it is difficult to conclude that such drugs are no different from placebo. The quality of the evidence may be estimated as 'moderate' because of imprecision. The major limitations of this review are that the results of the studies are quite diverse and the number of studies for one result is quite small.
Authors' conclusions: NSAIDs are somewhat effective in relieving the discomfort caused by a cold but there is no clear evidence of their effect in easing respiratory symptoms. The balance of benefit and harms needs to be considered when using NSAIDs for colds.
Conflict of interest statement
Soo Young Kim: none known. Yoon‐Jung Chang: none known. Hye Min Cho: none known. Ye‐Won Hwang: none known. Yoo Sun Moon: none known.
Figures
References
References to studies included in this review Goto 2007 {published data only}
- Goto M, Kawamura T, Shimbo T, Takahashi O, Ando M, Miyaki K, et al. Influence of loxoprofen use on recovery from naturally acquired upper respiratory tract infections: a randomized controlled trial. Internal Medicine 2006;46(15):1179‐86.
- Graham NM, Burrell CJ, Douglas RM, Debelle P, Davies L. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus‐infected volunteers. Journal of Infectious Diseases 1990;162(6):1277‐82.
- Itoh K, Nagaoka S, Hamada A, Noguchi E, Suzuki H, Taniai T, et al. A double‐blind clinical study of ketoprofen on acute upper respiratory infection ‐ comparison with aspirin. Clinical Evaluation 1980;8(2):457‐79.
- Katsu M, Oishi A, Nakamura H, Matsuoka Y, Irimajiri S, Kobayashi H, et al. Clinical evaluation of loxoprofen sodium (CS‐600E) on upper respiratory tract inflammation: a double blind controlled study in comparison with ibuprofen. Journal of Clinical Therapeutics and Medicines 1993;9(10):2299‐320.
- Nagaoka S, Nagahama F, Kunno K, Haga T, Ito K, Ito F, et al. Therapeutic effects of fentiazac on common cold ‐ a double‐blind clinical study. Clinical Evaluation 1980;8(3):757‐88.
- Ryan PB, Rush DR, Nicholas TA, Graham DG. A double‐blind comparison of fenoprofen calcium, acetaminophen, and placebo in the palliative treatment of common nonbacterial upper respiratory infections. Current Therapeutic Research, Clinical and Experimental 1987;41(1):17‐23.
- Sperber SJ, Sorrentino JV, Riker DK, Hayden FG. Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds. Bulletin of the New York Academy of Medicine 1989;65(1):145‐60.
- Sperber SJ, Hendley JO, Hayden FG, Riker DK, Sorrentino JV, Gwaltney JM Jr. Effects of naproxen on experimental rhinovirus colds. A randomized, double‐blind, controlled trial. Annals of Internal Medicine 1992;117(1):37‐41.
- Winther B, Mygind N. The therapeutic effectiveness of ibuprofen on the symptoms of naturally acquired common colds. American Journal of Rhinology 2001;15(4):239‐42.
- Aggarwal P, Ambrose C, Kumar M, Bhavani V, Bose E, Bose S, et al. Piroxicam versus ibuprofen as adjuncts to antibiotic therapy for symptomatic relief in upper respiratory infections: a perspective, randomized, comparative, multicentre study. Indian Practitioner 1997;50(11):939‐47.
- Azuma A, Kudoh S, Nakashima M, Nagatake T. A double‐blind study of zaltoprofen for the treatment of upper respiratory tract infection. Pharmacology 2010;85(1):41‐7.
- Azuma A, Kudoh S, Nakashima M, Nagatake T. Antipyretic and analgesic effects of zaltoprofen for the treatment of acute upper respiratory tract infection: verification of a non‐inferiority hypothesis using loxoprofen sodium. Pharmacology 2011;87(3‐4):204‐13.
- Bachert C, Chuchalin AG, Eisebitt R, Netayzhenko VZ, Voelker M. Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults; a multicenter, randomized, double‐blind, double‐dummy, placebo‐controlled, parallel‐group, single‐dose, 6‐hour dose‐ranging study. Clinical Therapeutics 2005;27(7):993‐1003.
- Banchini G, Scaricabarozzi I, Montecorboli U, Ceccarelli A, Chiesa F, Ditri L, et al. Double‐blind study of nimesulide in divers with inflammatory disorders of the ear, nose and throat. Drugs 1993;46(Suppl 1):100‐2.
- Batista NA, Zago MC, Schincarioli SM, Nader MC, Almeida J. Clinical evaluation of diclofenac resinate drops, associated to antibiotics, in the treatment of upper respiratory tract infections. Comparative study in pediatrics. Arquivos Brasileiros de Medicina 1985;59(6):479‐84.
- Bellussi L, Passali D. Treatment of upper airways inflammation with nimesulide. Drugs 1993;46(Suppl 1):107‐10.
- Bellussi L, Biagini C, Calearo C, Cenacchi V, Campora E, Girolamo A, et al. Antiphlogistic therapy with ketoprofen lysine salt vs nimesulide in secretive otitis media, rhinitis/rhinosinusitis, pharyngitis/tonsillitis/tracheitis. Otorinolaringologia 1996;46(1):49‐57.
- Benrimoj SI, Langford JH, Christian J, Charlesworth A, Steans A. Efficacy and tolerability of the anti‐inflammatory throat lozenge flurbiprofen 8.75mg in the treatment of sore throat: a randomised, double‐blind, placebo‐controlled study. Clinical Drug Investigation 2001;21(3):183‐93.
- Bernstein JE, Nelson FK. A double blind evaluation of an aspirin containing gum tablet for relief of the pain of common sore throat. Journal of International Medical Research 1974;2(1):76‐80.
- Blagden M, Christian J, Miller K, Charlesworth A. Multidose flurbiprofen 8.75 mg lozenges in the treatment of sore throat: a randomised, double‐blind, placebo‐controlled study in UK general practice centres. International Journal of Clinical Practice 2002;56(2):95‐100.
- Bonifaci E, Giorgi CM, Vibelli C. Symptomatic management of acute inflammation of the upper airways in paediatric patients. Minerva Pediatrica 1977;29(5):285‐96.
- Cappella L, Guerra A, Laudizi L, Cavazzuti GB. Efficacy and tolerability of nimesulide and lysine‐acetylsalicylate in the treatment of paediatric acute upper respiratory tract inflammation. Drugs 1993;46(Suppl 1):222‐5.
- Chachtel BP, McCabe D, Berger M, Zhang R, Sanner KM, Savino L, et al. Efficacy of low‐dose celecoxib in patients with acute pain. Journal of Pain 2011;12(7):756.
- Ebel DL, Shih WJ, Rhymer AR. A multi‐centre, double‐blind randomized study to assess the efficacy and tolerance of sulindac versus placebo in the symptomatic treatment of patients with upper respiratory tract infection. Current Medical Research and Opinion 1985;9(10):666‐75.
- Eccles R, Loose I, Jawad M, Nyman L. Effects of acetylsalicylic acid on sore throat pain and other pain symptoms associated with acute upper respiratory tract infection. Pain Medicine 2003;4(2):118‐24.
- Fujimori I, Kono M, Takeda Y, Sekita K, Katsu M, Adachi M, et al. Clinical evaluation of Clinoril tablets in acute upper respiratory tract infections. Kansenshogaku Zasshi 1982;56(12):1186‐95.
- Fujimori I, Kono M, Sekita T, Takeda Y, Ogihara K, Nakagawa H, et al. A double‐blind clinical evaluation of suprofen on acute upper respiratory infection. Comparison with aspirin. Kansenshogaku Zasshi 1983;57(1):62‐81.
- Gehanno P, Dreiser RL, Ionescu E, Gold M, Liu JM. Lowest effective single dose of diclofenac for antipyretic and analgesic effects in acute febrile sore throat. Clinical Drug Investigation 2003;23(4):263‐71.
- Gruber CM Jr, Collins T. Dose response to fenoprofen in an antipyretic study of fenoprofen and propoxyphene. Journal of Medicine 1977;8(1):27‐34.
- Kandoth PW, Joshi MK, Joshi VR, Satoskar RS. Comparative evaluation of antipyretic activity of ibuprofen and aspirin in children with pyrexia of varied aetiology. Journal of International Medical Research 1984;12(5):292‐7.
- Katsu M, Mashita H, Fujimori I, Shimada S, Fujii T. Therapeutic effects of fenbufen in common cold: multi‐clinic double‐blind study. Kansenshogaku Zasshi 1977;51(4):184‐96.
- Katsu M, Fujii T, Fujimori I, Katayama T, Harada K, Koizumi H, et al. Therapeutic utility of naproxen on acute upper respiratory infection: multi‐clinical double‐blind study. Kansenshogaku Zasshi 1978;52(5):148‐63.
- Katsu M, Hayakawa M, Kawai M, Fujimori I, Kohno M, Takeda Y, et al. Double blind controlled study of miroprofen in acute upper respiratory tract infections ‐ comparison with ibuprofen. Kansenshogaku Zasshi 1982;56(5):434‐53.
- Katsu M, Adachi M, Hayakawa M, Fujimori I, Kohno M, Takeda Y, et al. Clinical evaluation of sulindac (CLINORIL) in the treatment of acute upper respiratory tract infection: double‐blind comparison with ibuprofen. Kansenshogaku Zasshi 1983;57(3):260‐72.
- Kierszenbaum J, Vitral BG, Kierszenbaum AML, Sousa PR. Evaluation of nimesulid oral suspension versus diclofenac resinate in upper respiratory tract infections in the pediatrics. Pediatria Moderna 1991;27(7):560‐2.
- Lopes FO. Amoxicillin versus amoxicillin + nimesulide in otolaryngologic infections ‐ a randomized study. Folha Medica 1991;102(3):81‐5.
- Martinez Gallardo F, Lopez Fiesco A, Zamora G. Symptomatic treatment of common cold in children with a new combination of naproxen sodium plus pseudoephedrine hydrochloride: a comparative trial against pseudoephedrine syrup. Proceedings of the Western Pharmacology Society 1994;37:157‐8.
- Matsumoto K, Fujimori I, Tsubura E, Sakuma A, Hayashi M, Kudo K, et al. Clinical evaluation of oxaprozin in the treatment of acute upper respiratory tract inflammations: a double‐blind comparative study using ibuprofen as the control drug. Kansenshogaku Zasshi 1984;58(7):628‐46.
- Moore N, Parc JM, Ganse E, Wall R, Schneid H, Cairns R. Tolerability of ibuprofen, aspirin and paracetamol for the treatment of cold and flu symptoms and sore throat pain. International Journal of Clinical Practice 2002;56(10):732‐4.
- Nagaoka S, Fumio N, Ohito O, Hideyo N, Morise M, Osamu T, et al. Clinical effect of floctafenine in acute upper respiratory infection: a double blind test in comparison with aspirin. Japanese Pharmacology and Therapeutics 1985;13(2):981‐1010.
- Nagaoka S, Hiraga H, Ohito O, Hideyo N, Suetsugu S, Osamu T, et al. Clinical effect of emorfazone in acute upper respiratory infection: a double‐blind test in comparison with aspirin. Japanese Pharmacology and Therapeutics 1986;14(9):5883‐900.
- Nagaoka S, Nakamura S, Umehara Y, Nagahama F, Okayasu M, Noguchi E, et al. Clinical evaluation of tolfenamic acid on acute upper respiratory tract inflammation: multi‐center double‐blind study with ibuprofen. Journal of Clinical Therapeutics and Medicines 1986;2(2):221‐50.
- Nouri ME. Nimesulide for treatment of acute inflammation of the upper respiratory tract. Clinical Therapeutics 1984;6(2):142‐50.
- Nouri E, Monti T. Nimesulide granules for the treatment of acute inflammation of the ear, nose or throat. Drugs 1993;46(Suppl 1):103‐6.
- Pagella F, Rossi V, Zanoletti E, Benazzo M, Mira E. Efficacy and tolerability of a mouthwash based on diclofenac in the treatment of disorders of the upper respiratory tract. Double blind study versus flurbiprofen mouthwash. Otorinolaringologia 2001;51(2):77‐81.
- Passali D, Bellussi L, Ciferri G, Scaricabarozzi I. Use of nimesulide in inflammations of the upper respiratory tract. Clinica Terapeutica 1989;128(2):105‐11.
- Passali D, Gorga A, Ferri R, Bellussi L. Controlled clinical study on the efficacy and tolerability of methoxibutropate versus nimesulide in otorhinolaryngology. Otorinolaringologia 1997;47(3):145‐50.
- Reiner M. Nimesulide and antibiotics in the treatment of acute infections of the respiratory tract. Current Medical Research and Opinion 1983;8(7):487‐92.
- Ruperto N, Carozzino L, Jamone R, Freschi F, Picollo G, Zera M, et al. A randomized, double‐blind, placebo‐controlled trial of paracetamol and ketoprofren lysine salt for pain control in children with pharyngotonsillitis cared by family pediatricians. Italian Journal of Pediatrics 2011;37:1.
- Russo M, Bloch M, Looze FD, Morris C, Shephard A. Flurbiprofen microgranules for relief of sore throat: a randomised, double‐blind trial. British Journal of General Practice 2013;63:607.
- Salmon Rodriguez LE, Arista Viveros HA, Lopez E, Trujillo C, Maciel R, Lujan M. Evaluation of the efficacy and safety of nimesulide and naproxen in the symptomatic treatment of upper respiratory tract infections in children. A comparative blind study. Investigacion Medica Internacional 1993;20(2):43‐54.
- Salzberg R, Giambonini S, Maurizio M, Roulet D, Zahn J, Monti T. A double‐blind comparison of nimesulide and mefenamic acid in the treatment of acute upper respiratory tract infections in children. Drugs 1993;46(Suppl 1):208‐11.
- Sanchez Gonzalez A, Gonzalez Galindo T, Santana Hurtado O. Efficacy and safety assessment of tolmetin sodium (400 mg tid) vs naproxen sodium (275 mg tid) for the treatment of acute upper respiratory tract infection symptoms. Investigacion Medica Internacional 1999;26(1):3‐8.
- Schachtel BP, Thoden WR. A placebo‐controlled model for assaying systemic analgesics in children. Clinical Pharmacology and Therapeutics 1993;53(5):593‐601.
- Schachtel BP, Homan HD, Gibb IA, Christian J. Demonstration of dose response of flurbiprofen lozenges with the sore throat pain model. Clinical Pharmacology and Therapeutics 2002;71(5):375‐80.
- Stanley ED, Jackson GG, Panusarn C, Rubenis M, Dirda V. Increased virus shedding with aspirin treatment of rhinovirus infection. JAMA 1975;231(12):1248‐51.
- Tamura M, Ito T, Sudo M, Tazawa M, Sayama T, Yoshida M, et al. A double‐blind clinical evaluation of flurbiprofen on acute upper respiratory tract inflammation‐comparative study with ibuprofen. Kansenshogaku Zasshi 1984;58(12):1289‐303.
- Ulukol B, Koksal Y, Cin S. Assessment of the efficacy and safety of paracetamol, ibuprofen and nimesulide in children with upper respiratory tract infections. European Journal of Clinical Pharmacology 1999;55(9):615‐8.
- Vauzelle‐Kervroedan F, Revzani Y, Pons G, Consten L, Pariente‐Khayat A, D'Athis P, et al. Antipyretic efficacy of tiaprofenic acid in febrile children. Fundamental Clinical Pharmacology 1996;10(1):56‐9.
- Watson N, Nimmo WS, Christian J, Charlesworth A, Speight J, Miller K. Relief of sore throat with the anti‐inflammatory throat lozenge flurbiprofen 8.75 mg: a randomised, double‐blind, placebo‐controlled study of efficacy and safety. International Journal of Clinical Practice 2000;54(8):490‐6.
- AlBalawi ZH, Othman SS, AlFaleh K. Intranasal ipratropium bromide for the common cold. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD008231.pub3]
- Sutter A, Driel M, Kenyon L. Oral antihistamine‐decongestant‐analgesic combinations for the common cold. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD004976.pub2]
- Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infectious Diseases 2005;5(11):718‐25.
- Gwaltney JM. Viral respiratory infection therapy: historical perspectives and current trials. American Journal of Medicine 2002;112(Suppl 6A):33‐41.
- Heikkinen T, Jarvinen A. The common cold. Lancet 2003;361(9351):51‐9.
- Hernández‐Díaz S, Rodriguez LA. Association between nonsteroidal anti‐inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Archives of Internal Medicine 2000;160(14):2093‐9.
- Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐.
- Irwin RS, Madison JM. The diagnosis and treatment of cough. New England Journal of Medicine 2000;343(23):1715‐21.
- Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐.
- Li S, Yue J, Dong BR, Yang M, Lin X, Wu T. Acetaminophen (paracetamol) for the common cold in adults. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD008800.pub2]
- Matchaba P, Gitton X, Krammer G, Ehrsam E, Sloan VS, Olson M, et al. Risk of cardiovascular events and rofecoxib: cumulative meta‐analysis. Lancet 2004;364(9450):2021‐9.
- Ofman JJ, MacLean CH, Straus WL, Morton SC, Berger ML, Roth EA, et al. A meta‐analysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. Journal of Rheumatology 2002;29(4):804‐12.
- Ostberg B, Winther B, Borum P, Mygind N. Common cold and high‐dose ipratropium bromide: use of anticholinergic medication as an indicator of reflex‐mediated hypersecretion. Rhinology 1997;35(2):58‐62.
- Pratter MR. Cough and the common cold: ACCP evidence‐based clinical practice guidelines. Chest 2006;129(Suppl 1):72‐4.
- Saraswat A, Driel ML, Sutter AIM. Antihistamines for the common cold. Cochrane Database of Systematic Reviews 2011, Issue 10. [DOI: 10.1002/14651858.CD009345]
- Smith SM, Schroeder K, Fahey T. Over‐the‐counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database of Systematic Reviews 2014, Issue 11. [DOI: 10.1002/14651858.CD001831.pub5]
- Ta'i SH, Ferguson KAM, Singh HK, Sharma AN, Kumar S, Driel ML, et al. Nasal decongestants for the common cold. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD009612]
- Kim SY, Chang YJ, Cho HM, Hwang YW, Moon YS. Non‐steroidal anti‐inflammatory drugs for the common cold. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD006362]
- Kim Sy, Chang Y‐J, Cho HM, Hwang Y‐w, Moon YS. Non‐steroidal anti‐inflammatory drugs for the common cold. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD006362.pub2]
- Kim Sy, Chang Y‐J, Cho HM, Hwang Y‐w, Moon YS. Non‐steroidal anti‐inflammatory drugs for the common cold. Cochrane Database of Systematic Reviews 2011, Issue 10. [DOI: 10.1002/14651858.CD006362.pub2]
- Kim SY, Chang YJ, Cho HM, Hwang YW, Moon YS. Non‐steroidal anti‐inflammatory drugs for the common cold. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD006362.pub3]
Source: PubMed